Interleukin-18 in urine and serum of children with idiopathic nephrotic syndrome

Kidney and Blood Pressure Research

Volumn 31, Issue 2, 2008, Pages 122-126

  Kiliś Pstrusińska, Katarzyna ^a   Medyńska, Anna ^a   Zwolińska, Danuta ^a   Wawro, Anna ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Children; Idiopathic nephrotic syndrome; Immunological disorders; Interleukin 18

Indexed keywords

ALBUMIN; INTERLEUKIN 18;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEINURIA; RELAPSE; REMISSION;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INTERLEUKIN-18; MALE; NEPHROTIC SYNDROME; RECURRENCE; REMISSION INDUCTION;

EID: 43049090144     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000124284     Document Type: Article

References (24)

1. Schachter AD: The pediatric nephrotic syndrome spectrum: clinical homogeneity and molecular heterogeneity. Pediatr Transplant 2004;8:344-348.
2. International Study of Kidney Disease in Children: Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. Kidney Int 1978;13:159-165.
3. Lama G, Luongo L, Tirino G, Borriello A, Carangio C, Salsano ME: T-lymphocyte populations and cytokines in childhood nephrotic syndrome. Am J Kidney Dis 2002;39:958-965.
4. Araya CE, Wasserfall CH, Brusko TM, Mu W, Segal MS, Johnson RJ, Garin EH: A case of unfulfilled expectations. Cytokines in idiopathic minimal lesion nephrotic syndrome. Pediatr Nephrol 2006;21:603-610.
5. Van den Berg JG, Weening JJ: Role of immune system in the pathogenesis of idiopathic nephritic syndrome. Clin Sci 2004;107:125-136.
6. Dinarello CA: IL-18: a Th1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 1999;103:11-24.
7. Dinarello CA: Interleukin-18 and the pathogenesis of inflammatory diseases. Semin Nephrol 2007;27:98-114.
8. Ghayur T, Banerjee S, Hugunin M, Butler D, Herzog L, Carter A, Quintal L, Sekut L, Talanian R, Paskind M, Wong W, Kamen R, Tracey D, Allen H: Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN-γ production. Nature 1997;386:619-623.
9. Gracie JA, Robertson SE, McInnes IB: Interleukin-18. J Leukoc Biol 2003;73:213-224.
10. Wong CK, Ho CY, Li EK, Tam LS, Lam CW: Elevated production of interleukin-18 is associated with renal disease in patients with systemic lupus erythematosus. Clin Exp Immunol 2002;130:345-351.
11. Lonnemann G, Novick D, Rubinstein M, Dinarello CA: Interleukin-18, interleukin-18 binding protein and impaired production of interferon-γ in chronic renal failure. Clin Nephrol 2003;60:327-334.
12. Chiang CK, Hsu SP, Pai MF, Peng YS, Ho TI, Liu SH, Hung KY, Tsai TJ: Interleukin-18 is a strong predictor of hospitalization in hemodialysis patients. Nephrol Dial Transplant 2004;19:2810-2815.
13. Nguyen MT, Devarajan P: Biomarkers for the early detection of acute kidney injury. Pediatr Nephrol 2007 [March 30, E-pub ahead of print].
14. Washburn KK, Zappitelli M, Arikan AA, Loftis L, Yalavarthy R, Parikh CR, Edelstein CL, Goldstein SL: Urinary interleukin-18 is an acute kidney injury biomarker in critically ill children. Nephrol Dial Transplant 2008;23:5665-5672.
15. Matsumoto K, Kanmatsuse K: Augmented interleukin-18 production by peripheral blood monocytes in patients with minimal change nephritic syndrome. Am J Nephrol 2001;21:20-27.
16. Matsumoto K, Kanmatsuse K: Elevated interleukin-18 levels in the urine of nephritic patients. Nephron 2001;88:334-339.
17. International Study of Kidney Disease in Children: The primary nephrotic syndrome in children. Identification of patients with minimal change nephritic syndrome from initial response to prednisone. J Pediatr 1981;98:561-564.
18. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
19. Dinarello CA: Role of pro- and anti-inflammatory cytokines during inflammation: experimental and clinical findings. J Biol Regul Homeost Agents 1997;11:91-103.
20. Garcia GE, Xia Y, Ku G, Johnson RJ, Wilson CB, Feng L: IL-18 translational inhibition restricts IFN-γ expression in crescentic glomerulonephritis. Kidney Int 2003;64:160-169.
21. Matsumoto K, Kanmatsuse K: Interleukin-18 and interleukin-12 synergize to stimulate the production of vascular permeability factor by lymphocytes in normal subjects and in patients with minimal change nephritic syndrome. Nephron 2000;85:127-133.
22. Parikh CR, Jani A, Melnikov VY, Faubel S, Edelstein CL: Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis 2004;43:405-414.
23. Kitching AR, Turner AL, Wilson GR, Semple T, Odobasic D, Timoshanko JR, O'Sullivan KM, Tipping PG, Takeda K, Akira S, Holdsworth SR: IL-12p40 and IL-18 in crescentic glomerunephritis: IL-12p40 is the key Th-1 defining cytokine chain, whereas IL-18 promotes local inflammation in leukocyte recruitment. J Am Soc Nephrol 2005;16:2023-2033.
24. Faust J, Menke J, Kriegsmann J, Kelley VR, Mayet WJ, Galle PR, Schwarting A: Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis. Arthritis Rheum 2002;46:3083-3095.